Search
for
Sort by
Research 271–300 of 876
- Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Alopecia areata: An update
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Dermoscopy: what's new?
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- Bimatoprost in the treatment of eyelash universalis alopecia areata
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Dermoscopy of scalp tumours: a multi‐centre study conducted by the international dermoscopy society
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- Dermoscopy Research—An Update
- Cardiometabolic profile of young women with hypoprolactinemia
- Drug Delivery Applications of Three-Dimensional Printed (3DP) Mesoporous Scaffolds
- Gender-Affirming Hormone Therapy for Transgender Men
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Post-finasteride syndrome: An emerging clinical problem
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Optimization of menthol-loaded nanocapsules for skin application using the response surface methodology